Skip to Content
Merck
All Photos(1)

Documents

SML2803

Sigma-Aldrich

Tebanicline hydrochloride

≥98% (HPLC)

Synonym(s):

(R)-5-(2-Azetidinylmethoxy)-2-chloropyridine hydrochloride, (R)-5-(Azetidin-2-ylmethoxy)-2-chloropyridine hydrochloride, 5-((2R)-Azetidin-2-ylmethoxy)-2-chloropyridine hydrochloride, ABT-594 hydrochloride, Ebanicline hydrochloride

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C9H11ClN2O · xHCl
CAS Number:
Molecular Weight:
198.65 (free base basis)
UNSPSC Code:
12352200
NACRES:
NA.77

Quality Level

Assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to beige

solubility

H2O: 2 mg/mL, clear

storage temp.

−20°C

InChI

1S/C9H11ClN2O/c10-9-2-1-8(5-12-9)13-6-7-3-4-11-7/h1-2,5,7,11H,3-4,6H2/t7-/m1/s1

InChI key

MKTAGSRKQIGEBH-SSDOTTSWSA-N

Biochem/physiol Actions

Tebanicline (ABT-594) is a partial agonist at neural nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes. It is a less toxic analog of epibatidine with potent antinociceptive effects.

Pictograms

Exclamation mark

Signal Word

Warning

Hazard Statements

Hazard Classifications

STOT SE 3

Target Organs

Central nervous system

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Takafumi Hayashi et al.
Neuroscience letters, 638, 46-50 (2016-12-13)
Tebanicline (ABT-594), an analogue of epibatidine, exhibits potent antinociceptive effects and high affinity for the nicotinic acetylcholine receptor in the central nervous system. We assessed whether tebanicline exerts an effect on various noxious stimuli and mediates the nicotine receptor or
Zhiyong Ding et al.
Psychopharmacology, 235(4), 1093-1105 (2018-01-15)
A novel rodent continuous performance test (CPT) was developed as one of the goals of the NEWMEDS (Novel Methods leading to New Medications in Depression and Schizophrenia) consortium to improve its translatability to the CPT test used in human subjects. The

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service